{"name":"MORPLAN LIMITED","company_number":"03801026","status":"Active","type":"Private Limited Company","incorporated":"1999-07-01","dissolved":null,"registered_office":"Bruton House, Stadium Way, Harlow, England, CM19 5FT","postcode":"CM19 5FT","sic_codes":[{"code":47910,"description":"Retail sale via mail order houses or via Internet"}],"principal_activity":"The principal activity of the company in the year under review was that of a trade supplier to the retail industry.","previous_names":[{"name":"ALPHARE LIMITED","changed_on":"1999-08-04"}],"warnings":[],"accounts":{"category":"Medium","year_end":"31 December","last_made_up_to":"2025-12-31","next_due":"2027-09-30"},"employees":{"count":0,"accounts_date":"2025-12-31"},"financials":[{"financial_date":"2025-12-31","turnover":14973444,"profit_loss":-335545,"net_assets":3394813,"cash":849140,"average_employees":0},{"financial_date":"2024-12-31","turnover":15787635,"profit_loss":-302765,"net_assets":3730358,"cash":542510,"average_employees":79},{"financial_date":"2023-12-31","turnover":17588155,"profit_loss":-329055,"net_assets":4033123,"cash":1209494,"average_employees":82},{"financial_date":"2022-12-31","turnover":17234436,"net_assets":4362178,"cash":1111383},{"financial_date":"2021-12-31","turnover":13158943,"net_assets":4496261,"cash":40506}],"officers":{"current":4,"resigned":17,"complete":true,"note":"Names and details of individual officers are on the People page (subscriber-only on this site) and free at Companies House."},"charges":{"total":7,"outstanding":3},"gazette_notices":[],"insolvency_outcome":null,"ai_summary":"Morplan Limited presents a mixed risk profile: the company remains solvent and benefits from group backing, operational discipline, and improving gross margins. However, the sustained five-year decline in net assets (45% erosion), sharp cash deterioration in 2024, and revenue contraction of over 10% present material concerns that cannot be dismissed. The near-term outlook is further pressured by regulatory cost increases effective April 2025. While the Raja Group's acquisition of Retif offers potential long-term strategic benefits, the immediate financial trajectory warrants careful monitoring, particularly regarding working capital adequacy and the pace of continued PPE write-offs.","website":"https://www.morplan.com/gb_en","links":{"page":"https://www.companiesintheuk.co.uk/ltd/morplan","people":"https://www.companiesintheuk.co.uk/company/morplan/people","filing_history":"https://www.companiesintheuk.co.uk/company/morplan/filing-history","companies_house":"https://find-and-update.company-information.service.gov.uk/company/03801026","financials":"https://www.companiesintheuk.co.uk/company/morplan/financial","control":"https://www.companiesintheuk.co.uk/company/morplan/control","charges":"https://www.companiesintheuk.co.uk/company/morplan/charges","ai_analysis":"https://www.companiesintheuk.co.uk/company/morplan/analysis"},"source":"CompaniesInTheUK, from Companies House, The Gazette and other public registers (see /support/about). Cite as: CompaniesInTheUK, https://www.companiesintheuk.co.uk/ltd/morplan"}